Owlet appoints Melissa Gonzales to board; brings women's health and consumer healthcare expertise

Owlet, Inc.

Melissa Gonzales appointed as Class I director effective July 18, 2023, term expiring at 2025 annual meeting.
Gonzales is President, Women's Health at Myriad Genetics (MYGN) and brings 20+ years healthcare experience.
She will receive annual cash retainer of $50k and initial RSU grant valued ~$150k prorated.
Owlet CEO cites Gonzales' expertise as key as company prepares to launch BabySat FDA-cleared pulse oximetry device.
Gonzales also serves as Board Chair of March of Dimes, Chicago.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Melissa Gonzales

Class I director

OWLT · Owlet, Inc.

Effective: 2023-07-18
Filed: July 21, 2023, 7:59 PM ET

appointed Melissa Gonzales to serve as a Class I director of the Board, effective July 18, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Melissa Gonzales was appointed as Class I director at Owlet, Inc..

Action: appointed
Role: Class I director

Exact text from the filing

appointed Melissa Gonzales to serve as a Class I director of the Board, effective July 18, 2023

View on SEC.gov

Owlet, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-23-025334

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.